Teachers Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Teachers Advisors’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$6.59M	Sell	124,583 -204,761	-62%	-$10.1M	0.01%	1233
2018 Q4	$13.5M	Buy	329,344 +4,212	+1%	+$158K	0.02%	777
2018 Q3	$12.4M	Buy	325,132 +1,588	+0.5%	+$70.3K	0.01%	978
2018 Q2	$14.6M	Buy	323,544 +22,765	+8%	+$1.04M	0.02%	908
2018 Q1	$14.5M	Buy	300,779 +12,525	+4%	+$699K	0.02%	870
2017 Q4	$11.3M	Buy	288,254 +14,004	+5%	+$523K	0.01%	986
2017 Q3	$8.52M	Buy	274,250 +17,123	+7%	+$482K	0.01%	1092
2017 Q2	$7.03M	Buy	257,127 +100,932	+65%	+$3M	0.01%	1168
2017 Q1	$5.76M	Buy	156,195 +126,513	+426%	+$3.19M	0.01%	1230
2016 Q4	$429K	Buy	29,682 +4,812	+19%	+$84.5K	﹤0.01%	2619
2016 Q3	$573K	Buy	24,870 +2,598	+12%	+$49.5K	﹤0.01%	2401
2016 Q2	$369K	Buy	22,272 +12,247	+122%	+$247K	﹤0.01%	2586
2016 Q1	$159K	Hold	10,025	–	–	﹤0.01%	2850
2015 Q4	$324K	Buy	10,025 +3,039	+44%	+$132K	﹤0.01%	2660
2015 Q3	$295K	Buy	+6,986	New	+$330K	﹤0.01%	2698

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Teachers Advisors's GBT Position: Q1 2019 in Review

Teachers Advisors reduced its Global Blood Therapeutics, Inc. (GBT) stake by 62% in Q1 2019, selling an estimated $10.1M and leaving 124,583 shares worth $6.59M. The position accounts for 0.01% of the portfolio, ranked #1233.

Teachers Advisors first reported a position in GBT in Q3 2015 and has held it in 15 quarters since. The position peaked at $14.6M in Q2 2018. 201 funds tracked by Wall St. Rank hold GBT as of Q1 2019.

Teachers Advisors held 124,583 shares of Global Blood Therapeutics, Inc. worth $6.59M as of Q1 2019.
Teachers Advisors sold 204,761 Global Blood Therapeutics, Inc. shares in Q1 2019, an estimated $10.1M.
Global Blood Therapeutics, Inc. made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1233 holding.
Teachers Advisors first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and has held it in 15 quarters since.
Teachers Advisors's Global Blood Therapeutics, Inc. position peaked at $14.6M in Q2 2018.
201 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.